FDA Inspection 883481 — Midwest Transplant Network

Midwest Transplant Network — FEI 3001238375

The FDA completed an inspection of Midwest Transplant Network on Jun 2, 2014 in Westwood, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 2, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Westwood, KS (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.